Adam J Baumgarten, MD
Cardiovascular Disease (Cardiology) · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 8
- 1 carrier
- Office
- 1
- Since medical school
- 23 years
- Graduated 2003
Offices
1 location · Regents Univ of California UCSF · 276 clinicians in this group
Looking this up.
Hospitals listed: Marinhealth Medical Center · Novato Community Hospital · Sonoma Valley Hospital. That is not proof they admit you there this week.
Plans that list them
8 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Baumgarten’s office at (415) 476-1000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A92273 · Current
Licensed to practise in California · since 2005 · expires 2027-03-31 · St. George'S University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Cardiovascular Disease
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Marinhealth Medical CenterGreenbrae, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of MarinHealthPatients rate it 3 of 5 · 76% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.66 (3.59 to 7.73) · 1,505 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.177, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025
- Novato Community HospitalNovato, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 84% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
- Sonoma Valley HospitalSonoma, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency departmentPatients rate it 4 of 5 · 79% would definitely recommend itOverall rating: 2 of 5 starsNo measure marked better or worse than the national rate
See every measure and the patient survey for Marinhealth Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 3 better, 8 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.66 (3.59 to 7.73) · 1,505 cases | Worse | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.177 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.85 (0 to 1.83) · 1,056 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.04 (0.72 to 1.36) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.34 (112.58 to 222.09) · 57 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 47 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.5 · 119 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.6 · 257 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 428 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 11.4 · 477 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 197 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,827 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.38) · 6,990 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.41) · 6,838 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.41 (0 to 3) · 664 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.86 (1.4 to 4.33) · 1,436 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.38 (3.68 to 17.08) · 705 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.38 (0.72 to 8.04) · 672 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.66 (0.18 to 3.15) · 300 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.56 (0 to 1.25) · 5,550 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 76 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.396 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 275 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22 · 427 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -20.3 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 3.3 · 494 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -4.9 · 499 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.9 · 435 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.6 to 8.4) · 93 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.2 (7.8 to 16) · 93 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.6 · 84 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 111 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (10.3 to 16.5) · 2,119 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.4) · 670 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,233 patients answered, 19% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 68% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 48% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
See every measure and the patient survey for Novato Community Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 3 the same, 0 worse of 3 measures. Readmissions: 0 better, 7 the same, 0 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0 to 2.06) · 213 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.85 (0.4 to 1.3) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.2 · 25 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10 · 111 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.1 · 140 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.3 · 42 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 627 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 1,872 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.46) · 1,796 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.92 (0.5 to 5.33) · 505 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0 to 3.36) · 317 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.2 (0.51 to 3.88) · 495 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.93 (0 to 17.29) · 323 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.88 (0.69 to 9.07) · 311 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.75 (0.22 to 3.27) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.41 (0 to 1.49) · 1,320 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.2 · 143 cases | None | Apr 2023 – Mar 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.6 · 108 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -31.9 · 121 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.1 · 150 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.6 · 143 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 118 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 27 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.5 to 16.5) · 930 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 184 cases | No different | Jan 2024 – Dec 2024 |
What patients said (334 patients answered, 30% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 83% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 78% |
| Doctors "always" listened carefully | 84% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 82% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 82% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 84% |
| Staff "always" explained possible side effects | 49% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Sonoma Valley Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 0 better, 6 the same, 0 worse of 6 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.11 (0.63 to 1.6) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.2 · 37 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.6 · 106 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 35 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 5.6 · 345 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.21 (0 to 0.44) · 713 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.05 to 0.48) · 660 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.36 (0.77 to 5.94) · 101 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.65 (0 to 3.38) · 27 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.31 (0.58 to 4.03) · 100 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.86 (0 to 18.76) · 28 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (0.84 to 9.45) · 27 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.12 (0 to 2.33) · 540 cases | No different | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.651 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.1 · 60 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 15.5 · 47 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18 · 105 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 47 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.6 (10.2 to 17.9) · 486 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.6 to 1.3) · 83 cases | No different | Jan 2024 – Dec 2024 |
What patients said (164 patients answered, 31% of those asked)
| Cleanliness | 4 |
| Nurse communication | 5 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 85% |
| Doctors "always" communicated well | 88% |
| Staff "always" explained | 65% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 84% |
| Doctors "always" listened carefully | 88% |
| Doctors "always" treated them with courtesy and respect | 92% |
| Patients who gave a rating of "9" or "10" (high) | 74% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 81% |
| Nurses "always" listened carefully | 82% |
| Nurses "always" treated them with courtesy and respect | 91% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 53% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$320,281
Medicare paid this office $320,281 for 2,079 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 820 | $145,863 | $105 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 494 | $37,751 | $23 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 171 | $34,024 | $98 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 114 | $16,404 | $141 |
| New patient visit (45+ min) | 113 | $14,735 | $130 |
See all 27 services
| Return visit (30+ min) | 820 | $145,863 | $105 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 494 | $37,751 | $23 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 171 | $34,024 | $98 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 114 | $16,404 | $141 |
| New patient visit (45+ min) | 113 | $14,735 | $130 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 240 | $13,143 | $55 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 147 | $8,605 | $58 |
| Transitional care management services for problem of at least moderate complexity | 35 | $6,678 | $180 |
| Outpatient heart rehabilitation with electrocardiogram (ecg) monitoring, quality health care professional services | 87 | $5,567 | $24 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 83 | $5,537 | $67 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 422 | $5,420 | $12 |
| External shock to heart to regulate heart beat | 37 | $3,502 | $90 |
| Anticoagulant management of patient taking warfarin | 17 | $3,092 | $9 |
| Ultrasound of heart with probe in esophagus, with report | 30 | $2,654 | $88 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 114 | $2,540 | $21 |
| Telephone medical discussion with physician, 21-30 minutes | 20 | $2,535 | $115 |
| Long return visit (40+ min) | 12 | $1,948 | $150 |
| Programming of dual lead pacemaker system | 54 | $1,747 | $27 |
| Ultrasound of heart blood flow, valves and chambers | 87 | $1,225 | $14 |
| Heart rhythm recording of continous external ekg over 8-15 days | 85 | $1,092 | $12 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 22 | $482 | $19 |
| Ultrasound of heart blood flow, valves and chambers | 31 | $462 | $15 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 16 | $264 | $17 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 88 | $218 | $2 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 15 | $211 | $12 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 16 | $164 | $10 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 32 | $83 | $3 |
Who their Medicare patients are
2,079 Original Medicare patients in 2024. Average age 80 · Under 65 2% · 85 and older 27% · Women 46% · Also on Medicaid 10% · Health risk score 1.43. At or below the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Coronary heart disease 49% · Atrial fibrillation 44% · Heart failure 30% · Chronic kidney disease 29% · Diabetes 23% · Depression 19% · Cancer 17% · Stroke 17% · COPD 13% · Dementia 10%.
The office billed $1,953,302, Medicare allowed $433,942 and paid $320,281; for 5,933 services of 37 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 2,079 | 5,933 | 80 | 1.43 | $1,953,302 | $320,281 |
| 2023 | 2,091 | 5,451 | 79 | 1.45 | $1,842,927 | $298,082 |
| 2022 | 1,915 | 4,938 | 80 | 1.45 | $1,625,869 | $270,944 |
| 2021 | 2,117 | 5,445 | 79 | 1.41 | $1,779,310 | $277,402 |
| 2020 | 1,861 | 4,363 | 79 | 1.51 | $1,524,402 | $223,312 |
| 2019 | 2,331 | 5,081 | 78 | 1.56 | $1,798,500 | $246,737 |
| 2018 | 1,817 | 4,367 | 78 | 1.49 | $683,500 | $248,617 |
| 2017 | 1,961 | 4,526 | 78 | 1.55 | $707,681 | $231,248 |
| 2016 | 1,941 | 4,529 | 77 | 1.46 | $728,177 | $239,109 |
| 2015 | 2,015 | 4,766 | 77 | 1.53 | $738,928 | $249,057 |
| 2014 | 1,803 | 4,065 | 77 | 1.38 | $663,578 | $221,029 |
| 2013 | 1,397 | 3,301 | 77 | 1.49 | $512,104 | $195,289 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 26 services
| Return visit (30+ min) | 762 | $126,418 | $102 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 481 | $34,816 | $23 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 153 | $32,202 | $101 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 279 | $16,085 | $58 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 102 | $15,189 | $145 |
| New patient visit (45+ min) | 117 | $15,073 | $129 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 209 | $12,633 | $58 |
| Transitional care management services for problem of at least moderate complexity | 37 | $6,750 | $178 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 91 | $6,447 | $70 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 337 | $4,292 | $11 |
| Anticoagulant management of patient taking warfarin | 20 | $3,125 | $9 |
| External shock to heart to regulate heart beat | 33 | $3,119 | $92 |
| Ultrasound of heart with probe in esophagus, with report | 30 | $2,794 | $90 |
| Programming of dual lead pacemaker system | 58 | $2,020 | $29 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 82 | $1,850 | $22 |
| Long return visit (40+ min) | 11 | $1,763 | $147 |
| Ultrasound of heart blood flow, valves and chambers | 94 | $1,421 | $15 |
| Telephone medical discussion with physician, 21-30 minutes | 17 | $1,408 | $83 |
| Outpatient heart rehabilitation with electrocardiogram (ecg) monitoring, quality health care professional services | 45 | $1,376 | $23 |
| Heart rhythm recording of continous external ekg over 8-15 days | 71 | $890 | $12 |
| Ultrasound of heart blood flow, valves and chambers | 35 | $544 | $15 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 26 | $518 | $20 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 12 | $261 | $22 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 94 | $247 | $3 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 14 | $173 | $12 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 36 | $97 | $3 |
2022: 30 services
| Return visit (30+ min) | 668 | $116,916 | $115 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 483 | $32,827 | $22 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 152 | $27,204 | $86 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 97 | $15,450 | $153 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 269 | $14,248 | $53 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 208 | $12,484 | $59 |
| New patient visit (45+ min) | 92 | $12,151 | $132 |
| Transitional care management services for problem of at least moderate complexity | 24 | $4,849 | $186 |
| Anticoagulant management of patient taking warfarin | 27 | $3,678 | $9 |
| Long return visit (40+ min) | 24 | $3,400 | $131 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 267 | $3,163 | $11 |
| Telephone medical discussion with physician, 21-30 minutes | 19 | $2,566 | $122 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 30 | $2,068 | $69 |
| External shock to heart to regulate heart beat | 24 | $2,064 | $83 |
| Programming of dual lead pacemaker system | 61 | $1,780 | $27 |
| Outpatient heart rehabilitation with electrocardiogram (ecg) monitoring, quality health care professional services | 35 | $1,762 | $24 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 79 | $1,762 | $21 |
| Ultrasound of heart with probe in esophagus, with report | 17 | $1,326 | $78 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 22 | $1,178 | $54 |
| Heart rhythm recording of continous external ekg over 8-15 days | 47 | $655 | $14 |
| Ultrasound of heart blood flow, valves and chambers | 32 | $473 | $15 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 27 | $464 | $17 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 18 | $375 | $20 |
| Ultrasound of heart blood flow, valves and chambers | 24 | $344 | $14 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 27 | $297 | $11 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 13 | $200 | $14 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 11 | $184 | $17 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 11 | $123 | $11 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 32 | $82 | $3 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 24 | $60 | $2 |
2021: 33 services
| Return visit (30+ min) | 675 | $108,104 | $101 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 529 | $31,556 | $23 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 127 | $19,412 | $89 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 319 | $18,222 | $57 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 92 | $15,737 | $166 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 203 | $12,733 | $61 |
| New patient visit (45+ min) | 85 | $11,237 | $132 |
| Transitional care management services for problem of at least moderate complexity | 31 | $6,261 | $184 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 81 | $5,297 | $65 |
| Anticoagulant management of patient taking warfarin | 31 | $4,895 | $9 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 67 | $4,547 | $68 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 237 | $3,414 | $12 |
| External shock to heart to regulate heart beat | 34 | $3,343 | $90 |
| Telephone medical discussion with physician, 21-30 minutes | 29 | $3,168 | $99 |
| Programming of dual lead pacemaker system | 78 | $2,731 | $29 |
| Long return visit (40+ min) | 17 | $2,606 | $124 |
| Ultrasound of heart with probe in esophagus, with report | 27 | $2,463 | $91 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 85 | $2,069 | $23 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 71 | $1,363 | $19 |
| Ultrasound of heart blood flow, valves and chambers | 68 | $952 | $14 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 74 | $952 | $13 |
| Outpatient heart rehabilitation with electrocardiogram (ecg) monitoring, quality health care professional services | 19 | $873 | $24 |
| Heart rhythm recording of continous external ekg over 8-15 days | 48 | $779 | $15 |
| Ultrasound of heart blood flow, valves and chambers | 40 | $644 | $16 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 28 | $642 | $21 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 25 | $434 | $17 |
| Telephone or internet assessment with verbal and written report by consulting physician, 21-30 minutes | 17 | $299 | $18 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 37 | $294 | $7 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 24 | $292 | $12 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 14 | $245 | $15 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 11 | $207 | $19 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 68 | $167 | $2 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 40 | $115 | $3 |
2020: 30 services
| Return visit (30+ min) | 578 | $84,247 | $89 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 506 | $29,065 | $24 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 110 | $19,141 | $89 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 286 | $17,342 | $60 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 67 | $11,673 | $172 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 142 | $8,885 | $62 |
| New patient visit (45+ min) | 65 | $8,585 | $132 |
| Transitional care management services for problem of at least moderate complexity | 26 | $5,071 | $169 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 61 | $4,478 | $73 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 61 | $3,999 | $66 |
| External shock to heart to regulate heart beat | 31 | $2,901 | $91 |
| Anticoagulant management of patient taking warfarin | 30 | $2,629 | $11 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 180 | $2,505 | $13 |
| Short return visit (20+ min) | 47 | $2,289 | $48 |
| Ultrasound of heart with probe in esophagus, with report | 19 | $1,813 | $95 |
| Telephone or internet assessment with verbal and written report by consulting physician, 21-30 minutes | 38 | $1,764 | $43 |
| Programming of dual lead pacemaker system | 46 | $1,516 | $32 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 60 | $1,386 | $23 |
| External ekg recording for more than 48 hours up to 21 days | 40 | $1,030 | $25 |
| Return visit (30+ min) | 11 | $960 | $69 |
| Ultrasound of heart blood flow, valves and chambers | 62 | $952 | $15 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 110 | $845 | $7 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 34 | $660 | $19 |
| Outpatient heart rehabilitation with electrocardiogram (ecg) monitoring, quality health care professional services | 13 | $643 | $24 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 34 | $443 | $13 |
| Ultrasound of heart blood flow, valves and chambers | 25 | $401 | $16 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 14 | $271 | $19 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 14 | $182 | $13 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 62 | $166 | $3 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 24 | $67 | $3 |
2019: 29 services
| Return visit (30+ min) | 554 | $84,569 | $90 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 152 | $26,534 | $88 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 363 | $24,999 | $24 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 296 | $18,537 | $62 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 236 | $15,062 | $62 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 83 | $14,399 | $167 |
| New patient visit (45+ min) | 71 | $9,365 | $132 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 702 | $5,722 | $7 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 79 | $5,353 | $68 |
| Programming of dual lead pacemaker system | 68 | $3,932 | $38 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 233 | $3,659 | $14 |
| Short return visit (20+ min) | 47 | $3,429 | $66 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 43 | $3,081 | $72 |
| Outpatient heart rehabilitation with electrocardiogram (ecg) monitoring, quality health care professional services | 56 | $2,657 | $22 |
| Transitional care management services for problem of high complexity | 12 | $2,500 | $208 |
| External shock to heart to regulate heart beat | 20 | $2,073 | $94 |
| Ultrasound of heart with probe in esophagus, with report | 21 | $1,949 | $93 |
| External ekg recording for more than 48 hours up to 21 days | 73 | $1,768 | $23 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 73 | $1,712 | $22 |
| Long return visit (40+ min) | 12 | $1,211 | $93 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 60 | $1,124 | $19 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 60 | $754 | $13 |
| Programming of single lead pacemaker system | 14 | $746 | $37 |
| Ultrasound of heart blood flow, valves and chambers | 43 | $665 | $15 |
| Ultrasound of heart blood flow, valves and chambers | 27 | $423 | $16 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 15 | $282 | $19 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 15 | $189 | $13 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 43 | $115 | $3 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 27 | $73 | $3 |
2018: 30 services
| Return visit (30+ min) | 485 | $76,703 | $90 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 145 | $30,303 | $91 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 282 | $19,182 | $25 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 99 | $17,672 | $175 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 212 | $13,523 | $63 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 204 | $13,328 | $65 |
| Long return visit (40+ min) | 74 | $8,671 | $113 |
| Transitional care management services for problem of high complexity | 35 | $7,769 | $210 |
| New patient visit (45+ min) | 62 | $7,743 | $125 |
| Programming of dual lead pacemaker system | 92 | $5,274 | $43 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 68 | $4,678 | $69 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 62 | $4,592 | $74 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 253 | $4,105 | $15 |
| Outpatient heart rehabilitation with electrocardiogram (ecg) monitoring, quality health care professional services | 80 | $3,658 | $22 |
| Ultrasound of heart with probe in esophagus, with report | 34 | $3,267 | $96 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 309 | $2,520 | $7 |
| External shock to heart to regulate heart beat | 21 | $2,055 | $98 |
| Short return visit (20+ min) | 28 | $1,609 | $55 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 68 | $1,327 | $19 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 44 | $1,013 | $23 |
| Hospital discharge day management, 30 minutes or less | 15 | $972 | $65 |
| Ultrasound of heart blood flow, valves and chambers | 61 | $963 | $16 |
| External ekg recording for more than 48 hours up to 21 days | 44 | $938 | $21 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 68 | $890 | $13 |
| Ultrasound of heart blood flow, valves and chambers | 39 | $632 | $16 |
| Electrocardiogram (ecg) 2-day continuous | 18 | $467 | $26 |
| Programming of single lead pacemaker system | 13 | $431 | $31 |
| Electrocardiogram (ecg) 2-day continuous with review by health care professional | 18 | $428 | $24 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 63 | $195 | $3 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 39 | $110 | $3 |
2017: 34 services
| Return visit (30+ min) | 435 | $62,285 | $83 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 136 | $26,011 | $90 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 103 | $18,445 | $172 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 221 | $12,335 | $55 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 253 | $11,351 | $27 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 184 | $10,170 | $55 |
| New patient visit (45+ min) | 60 | $8,154 | $136 |
| Long return visit (40+ min) | 50 | $7,013 | $121 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 84 | $5,579 | $66 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 67 | $4,932 | $74 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 13 | $4,743 | $365 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 173 | $4,660 | $22 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 546 | $4,595 | $7 |
| Outpatient heart rehabilitation with electrocardiogram (ecg) monitoring, quality health care professional services | 85 | $4,367 | $23 |
| Ultrasound of heart with probe in esophagus, with report | 42 | $4,152 | $92 |
| Transitional care management services for problem of high complexity | 19 | $3,859 | $203 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 246 | $3,856 | $14 |
| External shock to heart to regulate heart beat | 35 | $3,790 | $95 |
| Programming of dual lead pacemaker system | 100 | $3,621 | $29 |
| Critical care, first 30-74 minutes | 13 | $2,665 | $190 |
| Short return visit (20+ min) | 36 | $2,055 | $51 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 24 | $1,878 | $63 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 74 | $1,415 | $19 |
| Ultrasound of heart blood flow, valves and chambers | 68 | $1,080 | $16 |
| Long return visit (40+ min) | 11 | $1,059 | $96 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 74 | $948 | $13 |
| Hospital discharge day management, 30 minutes or less | 15 | $894 | $60 |
| External ekg recording for more than 48 hours up to 21 days | 37 | $837 | $23 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 37 | $827 | $22 |
| Ultrasound of heart blood flow, valves and chambers | 48 | $812 | $16 |
| Programming of single lead pacemaker system | 23 | $771 | $29 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 17 | $329 | $19 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 68 | $190 | $3 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 48 | $143 | $3 |
2016: 29 services
| Return visit (30+ min) | 439 | $76,023 | $89 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 118 | $20,507 | $171 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 111 | $17,907 | $90 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 279 | $15,620 | $55 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 227 | $12,129 | $53 |
| New patient visit (45+ min) | 82 | $11,027 | $134 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 101 | $6,888 | $68 |
| Outpatient heart rehabilitation with electrocardiogram (ecg) monitoring, quality health care professional services | 114 | $6,726 | $23 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 635 | $6,649 | $7 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 319 | $5,714 | $15 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 67 | $5,519 | $81 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 67 | $4,943 | $74 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 14 | $4,893 | $350 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 41 | $3,246 | $62 |
| Short return visit (20+ min) | 51 | $3,107 | $56 |
| Transitional care management services for problem of high complexity | 13 | $2,748 | $211 |
| Ultrasound of heart with probe in esophagus, with report | 20 | $2,114 | $106 |
| External shock to heart to regulate heart beat | 19 | $2,051 | $103 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 107 | $2,020 | $19 |
| Programming of dual lead pacemaker system | 54 | $1,997 | $36 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 107 | $1,318 | $12 |
| Hospital discharge day management, 30 minutes or less | 21 | $1,274 | $61 |
| Ultrasound of heart blood flow, valves and chambers | 67 | $1,081 | $16 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 33 | $816 | $23 |
| External ekg recording for more than 48 hours up to 21 days | 33 | $766 | $21 |
| Ultrasound of heart blood flow, valves and chambers | 27 | $436 | $16 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 19 | $369 | $19 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 67 | $188 | $3 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 27 | $76 | $3 |
2015: 31 services
| Return visit (30+ min) | 367 | $71,403 | $90 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 142 | $25,123 | $172 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 144 | $24,179 | $88 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 242 | $13,556 | $55 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 256 | $13,193 | $51 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 808 | $8,397 | $7 |
| Outpatient heart rehabilitation with electrocardiogram (ecg) monitoring, quality health care professional services | 116 | $8,053 | $23 |
| New patient visit (45+ min) | 58 | $8,039 | $139 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 88 | $7,122 | $81 |
| Insertion of pacemaker and upper and lower heart chamber electrode | 18 | $7,063 | $392 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 96 | $5,937 | $62 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 285 | $5,711 | $15 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 62 | $4,190 | $68 |
| New patient visit (60+ min) | 24 | $4,019 | $167 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 15 | $3,698 | $247 |
| Short return visit (20+ min) | 43 | $2,847 | $59 |
| Ultrasound of heart with probe in esophagus, with report | 26 | $2,785 | $103 |
| External shock to heart to regulate heart beat | 23 | $2,552 | $106 |
| Initial hospital observation care per day, typically 70 minutes | 15 | $2,155 | $144 |
| Long return visit (40+ min) | 14 | $1,962 | $131 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 98 | $1,712 | $17 |
| Hospital discharge day management, 30 minutes or less | 20 | $1,266 | $63 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 98 | $1,121 | $11 |
| Ultrasound of heart blood flow, valves and chambers | 64 | $953 | $15 |
| Programming of dual lead pacemaker system | 18 | $929 | $49 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 36 | $666 | $18 |
| Ultrasound of heart blood flow, valves and chambers | 37 | $606 | $16 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 27 | $331 | $12 |
| Outpatient heart rehabilitation, qualified health care professional services | 18 | $275 | $15 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 64 | $174 | $3 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 36 | $109 | $3 |
2014: 29 services
| Return visit (30+ min) | 343 | $62,738 | $87 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 129 | $24,655 | $88 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 120 | $20,663 | $171 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 239 | $12,675 | $52 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 216 | $12,137 | $55 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 106 | $8,555 | $79 |
| New patient visit (45+ min) | 46 | $6,298 | $137 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 624 | $6,265 | $7 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 99 | $6,231 | $63 |
| Outpatient heart rehabilitation with electrocardiogram (ecg) monitoring, quality health care professional services | 81 | $5,033 | $23 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 67 | $4,858 | $73 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 24 | $4,567 | $190 |
| New patient visit (60+ min) | 25 | $4,196 | $168 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 200 | $3,690 | $15 |
| Short return visit (20+ min) | 41 | $2,806 | $58 |
| Long return visit (40+ min) | 20 | $2,382 | $119 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 98 | $1,826 | $19 |
| External shock to heart to regulate heart beat | 17 | $1,810 | $101 |
| Ultrasound of heart with probe in esophagus, with report | 16 | $1,451 | $91 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 98 | $1,212 | $12 |
| Ultrasound of heart blood flow, valves and chambers | 66 | $1,057 | $16 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 41 | $824 | $19 |
| Hospital discharge day management, 30 minutes or less | 11 | $624 | $57 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 40 | $528 | $12 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 16 | $407 | $25 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 16 | $341 | $21 |
| Ultrasound of heart blood flow, valves and chambers | 21 | $336 | $16 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 67 | $196 | $3 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 21 | $61 | $3 |
2013: 29 services
| Return visit (30+ min) | 267 | $46,155 | $89 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 148 | $24,700 | $160 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 102 | $22,411 | $84 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 257 | $13,236 | $51 |
| New patient visit (45+ min) | 85 | $11,181 | $132 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 165 | $8,750 | $52 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 116 | $7,393 | $64 |
| Long return visit (40+ min) | 52 | $5,908 | $111 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 69 | $5,570 | $81 |
| Outpatient heart rehabilitation with electrocardiogram (ecg) monitoring, quality health care professional services | 81 | $4,908 | $23 |
| New patient visit (60+ min) | 27 | $4,321 | $160 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 15 | $3,607 | $240 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 198 | $3,536 | $16 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 46 | $3,221 | $70 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 215 | $3,188 | $7 |
| Short return visit (20+ min) | 38 | $2,404 | $59 |
| Ultrasound of heart with probe in esophagus, with report | 26 | $2,184 | $84 |
| External shock to heart to regulate heart beat | 21 | $2,050 | $98 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 86 | $1,510 | $18 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 86 | $1,014 | $12 |
| Hospital discharge day management, more than 30 minutes | 12 | $1,001 | $77 |
| Emergency department visit with moderate level of medical decision making | 11 | $943 | $86 |
| Hospital observation care on day of discharge | 15 | $874 | $58 |
| Ultrasound of heart blood flow, valves and chambers | 44 | $683 | $16 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 37 | $649 | $18 |
| Ultrasound of heart blood flow, valves and chambers | 31 | $456 | $15 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 37 | $440 | $12 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 44 | $136 | $3 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 31 | $90 | $3 |
Medicaid work
$9,320 in 2024
Medicaid paid $9,320 for 241 billed services this clinician did in 2024, up to 22 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 117 | $4,278 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, or leadless pacemaker system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 95 | $2,724 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 29 | $2,319 |
| 2024 | 241 | 3 | 22 | $9,320 |
| 2023 | 323 | 3 | 21 | $11,863 |
| 2022 | 152 | 4 | 16 | $7,501 |
| 2021 | 111 | 4 | 18 | $3,011 |
| 2020 | 97 | 4 | 15 | $3,604 |
| 2019 | 238 | 2 | 45 | $4,967 |
| 2018 | 162 | 1 | 35 | $2,949 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 161 | $5,529 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 66 | $3,578 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, or leadless pacemaker system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 96 | $2,756 |
2022
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 61 | $4,261 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 35 | $1,308 |
| Return visit (30+ min) | 32 | $1,183 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, or leadless pacemaker system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 24 | $750 |
2021
| Return visit (30+ min) | 70 | $1,665 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 15 | $838 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, or leadless pacemaker system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 12 | $284 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 14 | $223 |
2020
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 40 | $2,673 |
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 30 | $500 |
| Interrogation device evaluation(s) (remote), up to 90 days; single, dual, or multiple lead pacemaker system, or leadless pacemaker system with interim analysis, review(s) and report(s) by a physician or other qualified health care professional | 13 | $292 |
| Return visit (30+ min) | 14 | $139 |
2019
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 225 | $4,224 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 13 | $743 |
2018
| Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 162 | $2,949 |
Drugs they prescribed that Part D paid
$1,475,545
Pharmacies billed $1,475,545 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
6,650 generic and 1,190 brand-name prescriptions · $1,475,545 in drug cost · 21 antibiotic prescriptions to 15 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 563 | $728,088 | $1,293 |
| Xarelto | 172 | $230,726 | $1,341 |
| Entresto | 107 | $102,538 | $958 |
| Repatha Sureclick | 86 | $93,303 | $1,085 |
| Multaq | 50 | $79,883 | $1,598 |
See all 67 drugs
| Eliquis | 563 | $728,088 | $1,293 |
| Xarelto | 172 | $230,726 | $1,341 |
| Entresto | 107 | $102,538 | $958 |
| Repatha Sureclick | 86 | $93,303 | $1,085 |
| Multaq | 50 | $79,883 | $1,598 |
| Jardiance | 20 | $24,393 | $1,220 |
| Brilinta | 21 | $15,325 | $730 |
| Metoprolol | 741 | $12,207 | $16 |
| Rosuvastatin | 541 | $11,088 | $20 |
| Atorvastatin | 889 | $10,156 | $11 |
| Praluent | 13 | $9,682 | $745 |
| Dabigatran Etexilate | 25 | $6,746 | $270 |
| Ezetimibe | 183 | $6,402 | $35 |
| Amlodipine Besylate | 589 | $5,596 | $10 |
| Losartan | 400 | $5,451 | $14 |
| Diltiazem 24hr Er (Cd) | 110 | $4,744 | $43 |
| Colesevelam | 12 | $4,347 | $362 |
| Ranolazine Er | 22 | $4,003 | $182 |
| Lisinopril | 385 | $3,604 | $9 |
| Bumetanide | 71 | $3,047 | $43 |
| Potassium Chloride | 76 | $2,910 | $38 |
| Valsartan | 61 | $2,847 | $47 |
| Pravastatin | 134 | $2,513 | $19 |
| Carvedilol | 187 | $2,322 | $12 |
| Isosorbide Mononitrate Er | 123 | $2,102 | $17 |
| Clopidogrel | 106 | $2,014 | $19 |
| Warfarin | 95 | $1,902 | $20 |
| Metoprolol | 208 | $1,894 | $9 |
| Sotalol | 99 | $1,891 | $19 |
| Furosemide | 245 | $1,846 | $8 |
| Nebivolol | 31 | $1,737 | $56 |
| Hydralazine | 94 | $1,628 | $17 |
| Digoxin | 51 | $1,593 | $31 |
| Flecainide Acetate | 24 | $1,476 | $61 |
| Toprol Xl | 12 | $1,394 | $116 |
| Atenolol | 84 | $1,360 | $16 |
| Amiodarone | 20 | $1,293 | $65 |
| Eplerenone | 16 | $1,287 | $80 |
| Isosorbide Dinitrate | 13 | $1,263 | $97 |
| Olmesartan Medoxomil | 35 | $995 | $28 |
| Losartan-Hydrochlorothiazide | 35 | $987 | $28 |
| Benazepril | 52 | $909 | $17 |
| Hydrochlorothiazide | 140 | $909 | $6 |
| Diltiazem | 43 | $875 | $20 |
| Spironolactone | 69 | $724 | $10 |
| Simvastatin | 69 | $671 | $10 |
| Telmisartan | 22 | $632 | $29 |
| Chlorthalidone | 58 | $612 | $11 |
| Nitroglycerin | 25 | $555 | $22 |
| Cartia Xt | 12 | $503 | $42 |
| Doxazosin Mesylate | 18 | $475 | $26 |
| Irbesartan | 14 | $441 | $32 |
| Triamterene-Hydrochlorothiazid | 23 | $361 | $16 |
| Pantoprazole | 14 | $359 | $26 |
| Sotalol Af | 15 | $343 | $23 |
| Nadolol | 16 | $320 | $20 |
| Ramipril | 30 | $305 | $10 |
| Metformin | 26 | $303 | $12 |
| Lansoprazole | 11 | $271 | $25 |
| Verapamil Er | 14 | $175 | $12 |
| Benazepril-Hydrochlorothiazide | 11 | $165 | $15 |
| Bisoprolol | 11 | $113 | $10 |
| Lisinopril-Hydrochlorothiazide | 11 | $109 | $10 |
| Levothyroxine | 11 | $85 | $8 |
| Propranolol | 15 | $82 | $5 |
| Amoxicillin | 16 | $68 | $4 |
| Lovastatin | 15 | $21 | $1 |
Year by year
| 2024 | 7,840 | 1,094 | None | 15% | $1,475,545 |
| 2023 | 6,738 | 976 | None | 14% | $1,276,584 |
| 2022 | 5,916 | 829 | None | 15% | $1,083,128 |
| 2021 | 5,639 | 733 | None | 15% | $920,261 |
| 2020 | 5,002 | 615 | None | 17% | $782,056 |
| 2019 | 4,604 | 539 | 0% (0) | 19% | $676,397 |
| 2018 | 3,881 | 442 | None | 18% | $480,480 |
| 2017 | 3,250 | 367 | None | 21% | $345,807 |
| 2016 | 3,079 | 350 | None | 23% | $287,654 |
| 2015 | 2,564 | 293 | None | 23% | $174,087 |
| 2014 | 2,180 | 249 | None | 25% | $130,787 |
| 2013 | 1,600 | 215 | None | 22% | $77,001 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 60 drugs
| Eliquis | 475 | $620,955 | $1,307 |
| Xarelto | 153 | $219,284 | $1,433 |
| Multaq | 53 | $91,112 | $1,719 |
| Entresto | 58 | $72,228 | $1,245 |
| Repatha Sureclick | 60 | $62,703 | $1,045 |
| Metoprolol | 656 | $16,026 | $24 |
| Praluent | 19 | $13,171 | $693 |
| Atorvastatin | 835 | $12,640 | $15 |
| Rosuvastatin | 371 | $10,451 | $28 |
| Ezetimibe | 127 | $8,977 | $71 |
| Jardiance | 13 | $7,977 | $614 |
| Losartan | 276 | $5,990 | $22 |
| Lisinopril | 413 | $5,079 | $12 |
| Amlodipine Besylate | 515 | $4,986 | $10 |
| Diltiazem 24hr Er (Cd) | 80 | $4,819 | $60 |
| Ranolazine Er | 14 | $3,340 | $239 |
| Flecainide Acetate | 29 | $3,237 | $112 |
| Potassium Chloride | 94 | $2,985 | $32 |
| Isosorbide Mononitrate Er | 113 | $2,795 | $25 |
| Carvedilol | 153 | $2,781 | $18 |
| Furosemide | 268 | $2,737 | $10 |
| Clopidogrel | 105 | $2,643 | $25 |
| Eplerenone | 17 | $2,630 | $155 |
| Warfarin | 109 | $2,500 | $23 |
| Metoprolol | 216 | $2,345 | $11 |
| Digoxin | 72 | $2,134 | $30 |
| Hydralazine | 73 | $1,850 | $25 |
| Atenolol | 79 | $1,811 | $23 |
| Pravastatin | 85 | $1,727 | $20 |
| Isosorbide Dinitrate | 11 | $1,658 | $151 |
| Bumetanide | 35 | $1,555 | $44 |
| Valsartan | 37 | $1,523 | $41 |
| Olmesartan Medoxomil | 45 | $1,520 | $34 |
| Nebivolol | 18 | $1,493 | $83 |
| Sotalol | 76 | $1,480 | $19 |
| Midodrine | 12 | $1,238 | $103 |
| Benazepril | 34 | $980 | $29 |
| Losartan-Hydrochlorothiazide | 31 | $969 | $31 |
| Hydrochlorothiazide | 134 | $953 | $7 |
| Chlorthalidone | 67 | $931 | $14 |
| Diltiazem | 30 | $899 | $30 |
| Enalapril Maleate | 13 | $845 | $65 |
| Valsartan-Hydrochlorothiazide | 15 | $779 | $52 |
| Nitroglycerin | 28 | $753 | $27 |
| Verapamil Er | 17 | $674 | $40 |
| Nadolol | 16 | $658 | $41 |
| Cartia Xt | 15 | $638 | $43 |
| Telmisartan | 11 | $619 | $56 |
| Propranolol | 14 | $517 | $37 |
| Benazepril-Hydrochlorothiazide | 12 | $485 | $40 |
| Amiodarone | 17 | $466 | $27 |
| Spironolactone | 41 | $459 | $11 |
| Ramipril | 23 | $377 | $16 |
| Lovastatin | 18 | $366 | $20 |
| Simvastatin | 62 | $342 | $6 |
| Pantoprazole | 13 | $327 | $25 |
| Triamterene-Hydrochlorothiazid | 23 | $317 | $14 |
| Torsemide | 11 | $281 | $26 |
| Metformin | 11 | $150 | $14 |
| Amoxicillin | 20 | $33 | $2 |
2022: 53 drugs
| Eliquis | 452 | $519,597 | $1,150 |
| Xarelto | 126 | $173,993 | $1,381 |
| Multaq | 47 | $65,892 | $1,402 |
| Pradaxa | 31 | $38,643 | $1,247 |
| Entresto | 29 | $37,988 | $1,310 |
| Repatha Sureclick | 41 | $35,570 | $868 |
| Praluent | 21 | $24,396 | $1,162 |
| Rosuvastatin | 309 | $17,449 | $56 |
| Metoprolol | 602 | $14,875 | $25 |
| Ezetimibe | 129 | $11,076 | $86 |
| Atorvastatin | 735 | $10,820 | $15 |
| Losartan | 250 | $4,897 | $20 |
| Ranolazine Er | 18 | $4,351 | $242 |
| Diltiazem 24hr Er (Cd) | 83 | $4,339 | $52 |
| Lisinopril | 361 | $3,882 | $11 |
| Amlodipine Besylate | 439 | $3,564 | $8 |
| Bystolic | 11 | $3,497 | $318 |
| Eplerenone | 19 | $3,468 | $183 |
| Digoxin | 68 | $3,346 | $49 |
| Potassium Chloride | 69 | $3,201 | $46 |
| Flecainide Acetate | 24 | $2,747 | $114 |
| Toprol Xl | 11 | $2,712 | $247 |
| Isosorbide Mononitrate Er | 102 | $2,595 | $25 |
| Hydralazine | 90 | $2,594 | $29 |
| Carvedilol | 148 | $2,579 | $17 |
| Warfarin | 91 | $2,510 | $28 |
| Valsartan | 22 | $2,092 | $95 |
| Nebivolol | 18 | $2,010 | $112 |
| Olmesartan Medoxomil | 42 | $1,959 | $47 |
| Metoprolol | 191 | $1,912 | $10 |
| Furosemide | 200 | $1,910 | $10 |
| Clopidogrel | 89 | $1,805 | $20 |
| Valsartan-Hydrochlorothiazide | 18 | $1,721 | $96 |
| Sotalol | 70 | $1,691 | $24 |
| Verapamil Er | 26 | $1,675 | $64 |
| Pravastatin | 70 | $1,546 | $22 |
| Nadolol | 21 | $1,396 | $66 |
| Diltiazem | 32 | $1,165 | $36 |
| Atenolol | 68 | $1,083 | $16 |
| Losartan-Hydrochlorothiazide | 23 | $920 | $40 |
| Bumetanide | 13 | $884 | $68 |
| Metolazone | 15 | $857 | $57 |
| Hydrochlorothiazide | 163 | $824 | $5 |
| Simvastatin | 51 | $766 | $15 |
| Lovastatin | 24 | $720 | $30 |
| Enalapril Maleate | 12 | $716 | $60 |
| Benazepril | 32 | $657 | $21 |
| Amiodarone | 22 | $475 | $22 |
| Torsemide | 11 | $467 | $42 |
| Nitroglycerin | 24 | $454 | $19 |
| Spironolactone | 37 | $357 | $10 |
| Chlorthalidone | 18 | $352 | $20 |
| Ramipril | 16 | $158 | $10 |
2021: 56 drugs
| Eliquis | 352 | $362,459 | $1,030 |
| Xarelto | 139 | $181,489 | $1,306 |
| Multaq | 44 | $59,349 | $1,349 |
| Pradaxa | 39 | $40,649 | $1,042 |
| Entresto | 31 | $33,108 | $1,068 |
| Repatha Sureclick | 45 | $26,652 | $592 |
| Isosorbide Dinitrate | 13 | $26,280 | $2,022 |
| Praluent | 38 | $25,732 | $677 |
| Metoprolol | 494 | $12,818 | $26 |
| Rosuvastatin | 259 | $9,923 | $38 |
| Ezetimibe | 117 | $9,142 | $78 |
| Atorvastatin | 643 | $8,921 | $14 |
| Bystolic | 14 | $7,843 | $560 |
| Ranolazine Er | 25 | $7,029 | $281 |
| Losartan | 251 | $5,000 | $20 |
| Eplerenone | 28 | $4,694 | $168 |
| Potassium Chloride | 74 | $4,169 | $56 |
| Digoxin | 81 | $3,302 | $41 |
| Diltiazem 24hr Er (Cd) | 56 | $3,004 | $54 |
| Isosorbide Mononitrate Er | 101 | $2,837 | $28 |
| Amlodipine Besylate | 428 | $2,807 | $7 |
| Lisinopril | 357 | $2,754 | $8 |
| Carvedilol | 169 | $2,566 | $15 |
| Warfarin | 91 | $2,555 | $28 |
| Nadolol | 27 | $2,504 | $93 |
| Hydralazine | 96 | $2,344 | $24 |
| Flecainide Acetate | 25 | $2,114 | $85 |
| Metoprolol | 197 | $1,942 | $10 |
| Valsartan | 27 | $1,891 | $70 |
| Olmesartan Medoxomil | 34 | $1,854 | $55 |
| Enoxaparin | 14 | $1,767 | $126 |
| Pravastatin | 78 | $1,527 | $20 |
| Furosemide | 209 | $1,451 | $7 |
| Atenolol | 64 | $1,324 | $21 |
| Sotalol | 66 | $1,313 | $20 |
| Nitroglycerin | 42 | $1,207 | $29 |
| Bumetanide | 17 | $1,095 | $64 |
| Clopidogrel | 95 | $1,053 | $11 |
| Diltiazem | 23 | $949 | $41 |
| Midodrine | 11 | $830 | $75 |
| Hydrochlorothiazide | 147 | $793 | $5 |
| Verapamil Er | 15 | $771 | $51 |
| Simvastatin | 50 | $753 | $15 |
| Amiodarone | 31 | $690 | $22 |
| Labetalol | 12 | $632 | $53 |
| Benazepril-Hydrochlorothiazide | 11 | $571 | $52 |
| Benazepril | 34 | $531 | $16 |
| Irbesartan | 11 | $512 | $47 |
| Fenofibrate | 14 | $497 | $35 |
| Spironolactone | 47 | $426 | $9 |
| Losartan-Hydrochlorothiazide | 14 | $408 | $29 |
| Omeprazole | 12 | $311 | $26 |
| Pantoprazole | 12 | $260 | $22 |
| Lovastatin | 15 | $214 | $14 |
| Triamterene-Hydrochlorothiazid | 14 | $184 | $13 |
| Ramipril | 12 | $149 | $12 |
2020: 55 drugs
| Eliquis | 324 | $289,023 | $892 |
| Xarelto | 117 | $141,075 | $1,206 |
| Multaq | 47 | $48,204 | $1,026 |
| Pradaxa | 38 | $39,145 | $1,030 |
| Entresto | 33 | $30,573 | $926 |
| Repatha Sureclick | 33 | $19,558 | $593 |
| Bystolic | 35 | $15,113 | $432 |
| Praluent | 17 | $13,666 | $804 |
| Metoprolol | 455 | $13,514 | $30 |
| Rosuvastatin | 215 | $11,796 | $55 |
| Ranolazine Er | 35 | $11,386 | $325 |
| Ezetimibe | 103 | $10,282 | $100 |
| Atorvastatin | 535 | $9,242 | $17 |
| Brilinta | 11 | $9,226 | $839 |
| Potassium Chloride | 66 | $4,990 | $76 |
| Eplerenone | 26 | $4,451 | $171 |
| Losartan | 229 | $4,031 | $18 |
| Isosorbide Dinitrate | 27 | $4,010 | $149 |
| Hydralazine | 107 | $3,089 | $29 |
| Lisinopril | 331 | $2,941 | $9 |
| Warfarin | 88 | $2,613 | $30 |
| Sotalol | 70 | $2,430 | $35 |
| Carvedilol | 162 | $2,350 | $15 |
| Isosorbide Mononitrate Er | 64 | $2,213 | $35 |
| Digoxin | 46 | $2,163 | $47 |
| Toprol Xl | 12 | $1,900 | $158 |
| Flecainide Acetate | 16 | $1,806 | $113 |
| Wixela Inhub | 12 | $1,742 | $145 |
| Pravastatin | 71 | $1,704 | $24 |
| Nitroglycerin | 58 | $1,690 | $29 |
| Amlodipine Besylate | 287 | $1,673 | $6 |
| Metoprolol | 190 | $1,660 | $9 |
| Diltiazem 24hr Er (Cd) | 34 | $1,520 | $45 |
| Furosemide | 177 | $1,517 | $9 |
| Clopidogrel | 74 | $1,284 | $17 |
| Olmesartan Medoxomil | 32 | $1,123 | $35 |
| Bumetanide | 13 | $1,051 | $81 |
| Hydrochlorothiazide | 147 | $958 | $7 |
| Nadolol | 21 | $953 | $45 |
| Amiodarone | 27 | $874 | $32 |
| Dilt-Xr | 13 | $856 | $66 |
| Fenofibrate | 14 | $800 | $57 |
| Torsemide | 13 | $654 | $50 |
| Atenolol | 45 | $633 | $14 |
| Pantoprazole | 20 | $567 | $28 |
| Spironolactone | 43 | $556 | $13 |
| Valsartan | 11 | $545 | $50 |
| Irbesartan | 15 | $519 | $35 |
| Diltiazem | 16 | $500 | $31 |
| Simvastatin | 47 | $499 | $11 |
| Benazepril | 23 | $344 | $15 |
| Labetalol | 16 | $341 | $21 |
| Triamterene-Hydrochlorothiazid | 13 | $287 | $22 |
| Lovastatin | 13 | $148 | $11 |
| Lisinopril-Hydrochlorothiazide | 11 | $75 | $7 |
2019: 54 drugs
| Eliquis | 311 | $208,365 | $670 |
| Xarelto | 131 | $126,133 | $963 |
| Multaq | 58 | $47,519 | $819 |
| Praluent | 27 | $29,048 | $1,076 |
| Pradaxa | 30 | $27,541 | $918 |
| Entresto | 34 | $20,947 | $616 |
| Metoprolol | 368 | $16,420 | $45 |
| Ranolazine Er | 36 | $13,892 | $386 |
| Repatha Sureclick | 21 | $12,940 | $616 |
| Rosuvastatin | 200 | $9,995 | $50 |
| Bystolic | 26 | $9,472 | $364 |
| Ezetimibe | 102 | $8,449 | $83 |
| Atorvastatin | 426 | $8,162 | $19 |
| Brilinta | 19 | $7,060 | $372 |
| Potassium Chloride | 58 | $3,982 | $69 |
| Losartan | 245 | $3,664 | $15 |
| Sotalol | 84 | $3,467 | $41 |
| Eplerenone | 26 | $3,358 | $129 |
| Warfarin | 83 | $3,108 | $37 |
| Isosorbide Mononitrate Er | 87 | $3,086 | $35 |
| Toprol Xl | 25 | $2,930 | $117 |
| Digoxin | 48 | $2,842 | $59 |
| Nitroglycerin | 54 | $2,817 | $52 |
| Lisinopril | 308 | $2,643 | $9 |
| Amlodipine Besylate | 277 | $2,529 | $9 |
| Isosorbide Dinitrate | 19 | $2,349 | $124 |
| Carvedilol | 133 | $2,164 | $16 |
| Hydralazine | 109 | $2,148 | $20 |
| Pravastatin | 68 | $1,756 | $26 |
| Olmesartan Medoxomil | 20 | $1,742 | $87 |
| Metoprolol | 175 | $1,413 | $8 |
| Furosemide | 138 | $1,178 | $9 |
| Clopidogrel | 61 | $1,102 | $18 |
| Dilt-Xr | 16 | $993 | $62 |
| Cartia Xt | 24 | $924 | $39 |
| Fenofibrate | 17 | $898 | $53 |
| Hydrochlorothiazide | 111 | $865 | $8 |
| Nadolol | 14 | $786 | $56 |
| Simvastatin | 44 | $704 | $16 |
| Diltiazem 24hr Er (Cd) | 26 | $699 | $27 |
| Spironolactone | 29 | $633 | $22 |
| Pantoprazole | 26 | $532 | $20 |
| Propranolol | 14 | $532 | $38 |
| Amiodarone | 17 | $523 | $31 |
| Atenolol | 38 | $461 | $12 |
| Sotalol Af | 17 | $448 | $26 |
| Irbesartan | 25 | $414 | $17 |
| Benazepril | 36 | $359 | $10 |
| Chlorthalidone | 12 | $305 | $25 |
| Diltiazem | 12 | $226 | $19 |
| Lovastatin | 14 | $182 | $13 |
| Torsemide | 11 | $171 | $16 |
| Losartan-Hydrochlorothiazide | 11 | $144 | $13 |
| Lorazepam | 14 | $106 | $8 |
2018: 48 drugs
| Eliquis | 206 | $130,764 | $635 |
| Xarelto | 122 | $94,253 | $773 |
| Multaq | 50 | $39,172 | $783 |
| Pradaxa | 36 | $26,487 | $736 |
| Praluent | 16 | $23,185 | $1,449 |
| Ranexa | 40 | $21,374 | $534 |
| Repatha Sureclick | 12 | $14,169 | $1,181 |
| Metoprolol | 376 | $13,754 | $37 |
| Atorvastatin | 359 | $7,924 | $22 |
| Rosuvastatin | 148 | $7,139 | $48 |
| Ezetimibe | 70 | $5,313 | $76 |
| Nitroglycerin | 32 | $5,211 | $163 |
| Bystolic | 18 | $5,048 | $280 |
| Warfarin | 83 | $2,535 | $31 |
| Toprol Xl | 21 | $2,510 | $120 |
| Lisinopril | 289 | $2,478 | $9 |
| Losartan | 197 | $2,279 | $12 |
| Digoxin | 35 | $2,272 | $65 |
| Isosorbide Mononitrate Er | 83 | $2,252 | $27 |
| Hydralazine | 98 | $1,910 | $19 |
| Carvedilol | 115 | $1,765 | $15 |
| Potassium Chloride | 49 | $1,727 | $35 |
| Sotalol | 75 | $1,684 | $22 |
| Amlodipine Besylate | 231 | $1,675 | $7 |
| Digox | 13 | $1,153 | $89 |
| Metoprolol | 144 | $1,104 | $8 |
| Furosemide | 139 | $918 | $7 |
| Olmesartan Medoxomil | 15 | $917 | $61 |
| Dilt-Xr | 17 | $873 | $51 |
| Bumetanide | 23 | $812 | $35 |
| Valsartan | 14 | $781 | $56 |
| Clopidogrel | 39 | $747 | $19 |
| Diltiazem 24hr Er (Cd) | 37 | $716 | $19 |
| Hydrochlorothiazide | 117 | $704 | $6 |
| Pravastatin | 26 | $693 | $27 |
| Fenofibrate | 16 | $676 | $42 |
| Cartia Xt | 24 | $661 | $28 |
| Spironolactone | 32 | $607 | $19 |
| Sotalol Af | 11 | $590 | $54 |
| Propranolol | 11 | $573 | $52 |
| Simvastatin | 53 | $572 | $11 |
| Nadolol | 15 | $572 | $38 |
| Amiodarone | 17 | $480 | $28 |
| Atenolol | 41 | $411 | $10 |
| Irbesartan | 21 | $294 | $14 |
| Pantoprazole | 15 | $287 | $19 |
| Benazepril | 18 | $208 | $12 |
| Metformin | 11 | $51 | $5 |
2017: 45 drugs
| Xarelto | 105 | $79,910 | $761 |
| Eliquis | 138 | $69,045 | $500 |
| Multaq | 32 | $23,732 | $742 |
| Pradaxa | 38 | $23,510 | $619 |
| Praluent | 11 | $22,784 | $2,071 |
| Zetia | 32 | $11,146 | $348 |
| Ranexa | 20 | $10,182 | $509 |
| Metoprolol | 244 | $9,778 | $40 |
| Atorvastatin | 368 | $7,577 | $21 |
| Ezetimibe | 51 | $6,861 | $135 |
| Rosuvastatin | 83 | $5,235 | $63 |
| Spiriva | 11 | $4,075 | $370 |
| Nitroglycerin | 23 | $4,000 | $174 |
| Bystolic | 13 | $3,125 | $240 |
| Warfarin | 75 | $2,133 | $28 |
| Potassium Chloride | 47 | $2,021 | $43 |
| Digoxin | 30 | $1,995 | $67 |
| Lisinopril | 196 | $1,940 | $10 |
| Amlodipine Besylate | 204 | $1,818 | $9 |
| Losartan | 148 | $1,717 | $12 |
| Digox | 15 | $1,530 | $102 |
| Hydralazine | 57 | $1,470 | $26 |
| Carvedilol | 124 | $1,455 | $12 |
| Sotalol | 50 | $1,417 | $28 |
| Olmesartan Medoxomil | 12 | $1,394 | $116 |
| Clopidogrel | 71 | $1,309 | $18 |
| Metoprolol | 167 | $1,250 | $7 |
| Isosorbide Mononitrate Er | 47 | $1,079 | $23 |
| Enoxaparin | 14 | $1,073 | $77 |
| Diltiazem 24hr Er | 40 | $952 | $24 |
| Furosemide | 114 | $780 | $7 |
| Valsartan | 18 | $717 | $40 |
| Pravastatin | 33 | $682 | $21 |
| Hydrochlorothiazide | 89 | $636 | $7 |
| Spironolactone | 32 | $528 | $17 |
| Cartia Xt | 21 | $419 | $20 |
| Simvastatin | 53 | $387 | $7 |
| Digitek | 16 | $341 | $21 |
| Pantoprazole | 13 | $325 | $25 |
| Amiodarone | 19 | $300 | $16 |
| Quinapril | 12 | $263 | $22 |
| Omeprazole | 17 | $221 | $13 |
| Irbesartan | 23 | $200 | $9 |
| Atenolol | 37 | $183 | $5 |
| Benazepril | 16 | $180 | $11 |
2016: 48 drugs
| Xarelto | 146 | $76,264 | $522 |
| Eliquis | 59 | $24,591 | $417 |
| Pradaxa | 35 | $20,907 | $597 |
| Multaq | 23 | $19,670 | $855 |
| Praluent | 11 | $16,580 | $1,507 |
| Zetia | 60 | $16,480 | $275 |
| Crestor | 42 | $11,799 | $281 |
| Ranexa | 14 | $8,666 | $619 |
| Metoprolol | 210 | $7,181 | $34 |
| Atorvastatin | 315 | $6,616 | $21 |
| Nitroglycerin | 13 | $3,502 | $269 |
| Warfarin | 109 | $2,541 | $23 |
| Bystolic | 11 | $2,379 | $216 |
| Clopidogrel | 101 | $2,338 | $23 |
| Enoxaparin | 11 | $2,268 | $206 |
| Lisinopril | 201 | $1,987 | $10 |
| Digoxin | 42 | $1,914 | $46 |
| Amlodipine Besylate | 205 | $1,700 | $8 |
| Potassium Chloride | 33 | $1,361 | $41 |
| Diltiazem 24hr Er | 30 | $1,320 | $44 |
| Losartan | 130 | $1,284 | $10 |
| Rosuvastatin | 17 | $1,231 | $72 |
| Hydralazine | 58 | $1,218 | $21 |
| Carvedilol | 101 | $1,149 | $11 |
| Valsartan | 25 | $1,041 | $42 |
| Pravastatin | 37 | $1,034 | $28 |
| Metoprolol | 149 | $1,010 | $7 |
| Toprol Xl | 12 | $870 | $73 |
| Sotalol | 52 | $845 | $16 |
| Hydrochlorothiazide | 86 | $840 | $10 |
| Isosorbide Mononitrate Er | 60 | $804 | $13 |
| Furosemide | 115 | $733 | $6 |
| Pantoprazole | 26 | $506 | $19 |
| Simvastatin | 71 | $404 | $6 |
| Digitek | 15 | $404 | $27 |
| Bumetanide | 17 | $377 | $22 |
| Spironolactone | 26 | $366 | $14 |
| Propranolol | 11 | $333 | $30 |
| Quinapril | 13 | $318 | $24 |
| Amiodarone | 21 | $318 | $15 |
| Benazepril | 30 | $310 | $10 |
| Nitrostat | 12 | $295 | $25 |
| Enalapril Maleate | 12 | $212 | $18 |
| Irbesartan | 15 | $183 | $12 |
| Sotalol Af | 11 | $179 | $16 |
| Diltiazem | 13 | $121 | $9 |
| Atenolol | 11 | $55 | $5 |
| Glipizide | 13 | $43 | $3 |
2015: 42 drugs
| Xarelto | 106 | $52,162 | $492 |
| Pradaxa | 25 | $15,231 | $609 |
| Multaq | 11 | $12,727 | $1,157 |
| Eliquis | 31 | $10,399 | $335 |
| Crestor | 34 | $8,864 | $261 |
| Metoprolol | 191 | $6,553 | $34 |
| Zetia | 21 | $5,697 | $271 |
| Atorvastatin | 229 | $5,297 | $23 |
| Nitroglycerin | 11 | $3,662 | $333 |
| Warfarin | 117 | $3,356 | $29 |
| Enoxaparin | 14 | $2,549 | $182 |
| Clopidogrel | 122 | $2,546 | $21 |
| Valsartan-Hydrochlorothiazide | 13 | $2,117 | $163 |
| Digoxin | 40 | $2,108 | $53 |
| Valsartan | 15 | $1,948 | $130 |
| Bystolic | 15 | $1,919 | $128 |
| Potassium Chloride | 30 | $1,524 | $51 |
| Isosorbide Dinitrate | 13 | $1,497 | $115 |
| Lisinopril | 176 | $1,287 | $7 |
| Amlodipine Besylate | 172 | $1,246 | $7 |
| Hydrochlorothiazide | 119 | $1,059 | $9 |
| Pravastatin | 37 | $953 | $26 |
| Carvedilol | 74 | $892 | $12 |
| Losartan | 106 | $785 | $7 |
| Hydralazine | 43 | $779 | $18 |
| Metoprolol | 119 | $672 | $6 |
| Isosorbide Mononitrate Er | 45 | $583 | $13 |
| Furosemide | 96 | $570 | $6 |
| Pantoprazole | 29 | $468 | $16 |
| Digitek | 16 | $397 | $25 |
| Diltiazem 24hr Er | 11 | $358 | $33 |
| Nitrostat | 24 | $344 | $14 |
| Simvastatin | 70 | $329 | $5 |
| Sotalol | 25 | $299 | $12 |
| Diltiazem | 27 | $294 | $11 |
| Propranolol | 12 | $255 | $21 |
| Spironolactone | 34 | $252 | $7 |
| Amiodarone | 27 | $203 | $8 |
| Irbesartan | 12 | $132 | $11 |
| Benazepril | 12 | $129 | $11 |
| Ramipril | 12 | $88 | $7 |
| Atenolol | 13 | $82 | $6 |
2014: 36 drugs
| Xarelto | 47 | $25,220 | $537 |
| Multaq | 18 | $10,736 | $596 |
| Pradaxa | 16 | $9,534 | $596 |
| Crestor | 32 | $9,155 | $286 |
| Metoprolol | 186 | $7,707 | $41 |
| Atorvastatin | 149 | $4,883 | $33 |
| Eliquis | 15 | $4,668 | $311 |
| Clopidogrel | 92 | $2,735 | $30 |
| Zetia | 12 | $2,731 | $228 |
| Warfarin | 83 | $2,538 | $31 |
| Valsartan-Hydrochlorothiazide | 12 | $1,996 | $166 |
| Digoxin | 33 | $1,818 | $55 |
| Bystolic | 16 | $1,668 | $104 |
| Digox | 31 | $1,398 | $45 |
| Isosorbide Dinitrate | 14 | $1,352 | $97 |
| Lisinopril | 167 | $1,332 | $8 |
| Amlodipine Besylate | 155 | $1,322 | $9 |
| Potassium Chloride | 29 | $1,305 | $45 |
| Hydralazine | 50 | $1,258 | $25 |
| Losartan | 74 | $1,070 | $14 |
| Carvedilol | 66 | $965 | $15 |
| Nitrostat | 47 | $760 | $16 |
| Hydrochlorothiazide | 104 | $756 | $7 |
| Furosemide | 115 | $694 | $6 |
| Pravastatin | 20 | $653 | $33 |
| Metoprolol | 70 | $560 | $8 |
| Isosorbide Mononitrate Er | 36 | $533 | $15 |
| Sotalol | 18 | $482 | $27 |
| Simvastatin | 73 | $458 | $6 |
| Finasteride | 14 | $327 | $23 |
| Spironolactone | 31 | $319 | $10 |
| Amiodarone | 13 | $238 | $18 |
| Pantoprazole | 11 | $212 | $19 |
| Diltiazem | 22 | $201 | $9 |
| Benazepril | 13 | $140 | $11 |
| Atenolol | 14 | $39 | $3 |
2013: 26 drugs
| Pradaxa | 29 | $14,873 | $513 |
| Metoprolol | 148 | $6,095 | $41 |
| Enoxaparin | 16 | $5,860 | $366 |
| Atorvastatin | 136 | $4,840 | $36 |
| Crestor | 15 | $4,555 | $304 |
| Clopidogrel | 64 | $2,442 | $38 |
| Warfarin | 62 | $2,045 | $33 |
| Hydralazine | 30 | $1,218 | $41 |
| Carvedilol | 56 | $1,178 | $21 |
| Lisinopril | 154 | $1,145 | $7 |
| Amlodipine Besylate | 105 | $1,141 | $11 |
| Simvastatin | 84 | $870 | $10 |
| Losartan | 58 | $849 | $15 |
| Sotalol | 23 | $643 | $28 |
| Isosorbide Mononitrate Er | 35 | $618 | $18 |
| Potassium Chloride | 18 | $557 | $31 |
| Pravastatin | 18 | $546 | $30 |
| Hydrochlorothiazide | 76 | $490 | $6 |
| Metoprolol | 57 | $466 | $8 |
| Furosemide | 73 | $430 | $6 |
| Nitrostat | 29 | $376 | $13 |
| Tamsulosin | 15 | $348 | $23 |
| Digox | 22 | $292 | $13 |
| Spironolactone | 19 | $282 | $15 |
| Clonidine | 15 | $167 | $11 |
| Propranolol | 12 | $111 | $9 |
Money from drug and device companies
$24 in 2025
| 2025 | 1 | 1 | None | $24 |
| 2024 | 3 | 3 | None | $188 |
| 2023 | 1 | 2 | None | $41 |
| 2022 | 2 | 3 | None | $54 |
| 2021 | 1 | 1 | None | $26 |
| 2020 | 4 | 5 | None | $58 |
| 2019 | 9 | 20 | None | $656 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbott Laboratories | Pressurewire | $24 | 1 payment
|
See the published payment
| Abbott Laboratories | Meals · 2025-11-26 | Pressurewire | $24 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $188
| Edwards Lifesciences | Edwards Sapien 3 Ultra Transcatheter Heart Valve | $124 | 1 payment
|
| Boston Scientific | Watchman Flx | $42 | 1 payment
|
| Heartflow | Ffrct | $22 | 1 payment
|
2023: $41
| Medtronic | Linq II | $41 | 2 payments
|
2022: $54
| Abbott Laboratories | Assurity | $37 | 2 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $18 | 1 payment
|
2021: $26
| Lantheus Medical Imaging | Definity | $26 | 1 payment
|
2020: $58
| Lantheus Medical Imaging | Definity | $27 | 2 payments
|
| Medtronic Vascular | Tyrx | $14 | 1 payment
|
| Abbott Laboratories | Confirm Rx | $12 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $4 | 1 payment
|
2019: $656
| Abbott Laboratories | Mitra Clip System | $173 | 6 payments
|
| HeartFlow | None | $167 | 1 payment
|
| Boston Scientific | Watchman | $142 | 4 payments
|
| Janssen Pharmaceuticals | Xarelto | $45 | 3 payments
|
| Novartis Pharmaceuticals | Entresto | $43 | 2 payments
|
| Amgen | Repatha | $27 | 1 payment
|
| Regeneron Healthcare Solutions | Praluent | $22 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $19 | 1 payment
|
| Kowa Pharmaceuticals America | Livalo | $17 | 1 payment
|
Professional record
- NPI
- 1366570707
- Licence
- CA A92273California A92273: Current · expires 2027-03-31
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Cardiology (207RC0000X); Internal medicine (207R00000X)
- Mailing address
- 2 Bon Air Rd, Suite 100, Larkspur, CA, 94939
- NPI first listed
- 2007-02-28
- NPI last updated
- 2012-04-24
This is when the NPI record was last certified, not a medical board exam.